Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Share-based Compensation (2018 - 2025)

Phibro Animal Health (PAHC) has 6 years of Share-based Compensation data on record, last reported at $434000.0 in Q4 2025.

  • For Q4 2025, Share-based Compensation rose 141.11% year-over-year to $434000.0; the TTM value through Dec 2025 reached $1.1 million, up 68.05%, while the annual FY2025 figure was $717000.0, 50.95% up from the prior year.
  • Share-based Compensation reached $434000.0 in Q4 2025 per PAHC's latest filing, up from $339000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $434000.0 in Q4 2025 and bottomed at $80000.0 in Q4 2023.
  • Average Share-based Compensation over 3 years is $196500.0, with a median of $179000.0 recorded in 2024.
  • The widest YoY moves for Share-based Compensation: up 141.11% in 2025, down 0.0% in 2025.
  • A 3-year view of Share-based Compensation shows it stood at $80000.0 in 2023, then skyrocketed by 125.0% to $180000.0 in 2024, then skyrocketed by 141.11% to $434000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $434000.0 in Q4 2025, $339000.0 in Q3 2025, and $179000.0 in Q2 2025.